Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Wyatt R. Hack"'
Autor:
John C. Crabbe, Angela R. Ozburn, Robert J. Hitzemann, Stephanie E. Spence, Wyatt R. Hack, Jason P. Schlumbohm, Pamela Metten
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 4, Iss , Pp 100061- (2020)
Alcohol use disorders (AUDs) are prevalent, and are characterized by binge-like drinking, defined by patterns of focused drinking where dosages ingested in 2–4 h reach intoxicating blood alcohol levels (BALs). Current medications are few and com
Externí odkaz:
https://doaj.org/article/932849e6259a4bc9b698711fb648c549
Autor:
John C. Crabbe, Pamela Metten, Antonia M. Savarese, Angela R. Ozburn, Jason P. Schlumbohm, Stephanie E. Spence, Wyatt R. Hack
Publikováno v:
Brain Sciences, Vol 9, Iss 1, p 2 (2019)
Two independent lines of High Drinking in the Dark (HDID-1, HDID-2) mice have been bred to reach high blood alcohol levels after a short period of binge-like ethanol drinking. Male mice of both lines were shown to have reduced sensitivity to develop
Externí odkaz:
https://doaj.org/article/c76b96e7c61040148f41afe1a2e5fb6f
Autor:
Angela R. Ozburn, Felix Hausch, Hazel Hunt, John C. Crabbe, Michael Bauder, Kathryn LeMoine, Jason P. Schlumbohm, Pamela Metten, Antonia Savarese, Wyatt R. Hack
Publikováno v:
Alcohol Clin Exp Res
BACKGROUND: Chronic alcohol exposure can alter glucocorticoid receptor (GR) function in some brain areas that promotes escalated and compulsive-like alcohol intake. GR antagonism can prevent dependence-induced escalation in drinking, but very little
Publikováno v:
Addict Biol
We have modelled genetic risk for binge-like drinking by selectively breeding High Drinking in the Dark-1 and −2 (HDID-1 and HDID-2) mice for their propensity to reach intoxicating blood alcohol levels (BALs) after binge-like drinking in a single b
Autor:
Angela R. Ozburn, John C. Crabbe, Pamela Metten, Antonia Savarese, Jason P. Schlumbohm, Stephanie E. Spence, Wyatt R. Hack
Publikováno v:
Brain Sciences
Brain Sciences, Vol 9, Iss 1, p 2 (2019)
Volume 9
Issue 1
Brain Sciences, Vol 9, Iss 1, p 2 (2019)
Volume 9
Issue 1
Two independent lines of High Drinking in the Dark (HDID-1, HDID-2) mice have been bred to reach high blood alcohol levels after a short period of binge-like ethanol drinking. Male mice of both lines were shown to have reduced sensitivity to develop
Autor:
Pamela Metten, K. Matthew Lattal, John C. Crabbe, Jason P. Schlumbohm, Amanda M. Barkley-Levenson, Wyatt R. Hack
Publikováno v:
Alcohol. 52:25-32
The comorbidity of substance- and alcohol-use disorders (AUD) with other psychiatric conditions, especially those related to stress such as post-traumatic stress disorder (PTSD), is well-established. Binge-like intoxication is thought to be a crucial
Autor:
Jason P. Schlumbohm, Angela R. Ozburn, John C. Crabbe, Robert Hitzemann, Pamela Metten, Wyatt R. Hack, Stephanie E. Spence
Publikováno v:
Brain, Behavior, & Immunity-Health
Brain, Behavior, & Immunity-Health, Vol 4, Iss, Pp 100061-(2020)
Brain, Behavior, & Immunity-Health, Vol 4, Iss, Pp 100061-(2020)
Alcohol use disorders (AUDs) are prevalent, and are characterized by binge-like drinking, defined by patterns of focused drinking where dosages ingested in 2–4 h reach intoxicating blood alcohol levels (BALs). Current medications are few and com
Autor:
Lawrence C. Huang, John C. Crabbe, Jason P. Schlumbohm, Gian D. Greenberg, Wyatt R. Hack, Pamela Metten, Stephanie E. Spence
Publikováno v:
Alcohol (Fayetteville, N.Y.). 68
Despite acceptance that risk for alcohol-use disorder (AUD) has a large genetic component, the identification of genes underlying various components of risk for AUD has been hampered in humans, in part by the heterogeneity of expression of the phenot
Autor:
Angela R. Ozburn, Jason P. Schlumbohm, John C. Crabbe, Lawrence C. Huang, Amanda M. Barkley-Levenson, Stephanie E. Spence, Wyatt R. Hack, Pamela Metten
Publikováno v:
Pharmacology, biochemistry, and behavior. 160
Background There is a serious public health need for better understanding of alcohol use disorder disease mechanisms and for improved treatments. At this writing, only three drugs are approved by the Food and Drug Administration as medications to tre
Autor:
Savarese, Antonia M.1 (AUTHOR) savarese@ohsu.edu, Metten, Pamela1,2 (AUTHOR), Phillips, Tamara J.1,2 (AUTHOR), Jensen, Bryan E.1,2 (AUTHOR), Crabbe, John C.1,2 (AUTHOR), Ozburn, Angela R.1,2 (AUTHOR)
Publikováno v:
Addiction Biology. Sep2022, Vol. 27 Issue 5, p1-13. 13p.